Denise Rodriguez
Icahn School of Medicine at Mount Sinai
4 Papers
Denise Rodriguez is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Antigen & ABO blood group system. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.
Sean T. H. Liu,Hung-Mo Lin,Ian Baine,Ania Wajnberg,Jeffrey P. Gumprecht,Farah Rahman,Denise Rodriguez,Pranai Tandon,Adel Bassily-Marcus,Jeffrey Bander,Charles Sanky,Amy C. Dupper,Allen Zheng,Freddy T. Nguyen,Fatima Amanat,Daniel Stadlbauer,Deena R. Altman,Benjamin K. Chen,Florian Krammer,Damodara Rao Mendu,Adolfo Firpo-Betancourt,Matthew A. Levin,Emilia Bagiella,Arturo Casadevall,Carlos Cordon-Cardo,Jeffrey S. Jhang,Suzanne Arinsburg,David Reich,Judith A. Aberg,Nicole M. Bouvier +29 more
TL;DR: Convalescent plasma is potentially effective against COVID-19, but adequately powered, randomized controlled trials are needed.
Abstract CT108: Immunogenicity of Poly-ICLC matured dendritic cells as an adjuvant for NY-ESO-1 and Melan-A-MART-1 peptide vaccination compared to Montanide® ISA-51 VG, in study subjects with melanoma in complete clinical remission but at high risk of disease recurrence
Mansi Saxena,Ashleih Burke,Anna C. Pavlick,Ana Blázquez,Gustavo Gimenez,Marcia Meseck,Michael J. Donovan,Denise Rodriguez,Mireia Castillo-Martin,Tin Htwe Thin,Rachel Lubong Sabado,John Mandeli,Sacha Gnjatic,Philip Friedlander,Nina Bhardwaj +14 more
TL;DR: A Phase II open-label, randomized, two-arm study to compare two approaches for engaging DCs and inducing an immune response to tumor antigens in the absence of tumor, concluding that the Arm A vaccine appears to be more efficient at eliciting CD8+ T cell responses against MelanA/MART1.
2
Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2.
Freddy T. Nguyen,Freddy T. Nguyen,Tayler van den Akker,Kimberly Lally,Hansen Lam,Volha Lenskaya,Sean T. H. Liu,Nicole M. Bouvier,Judith A. Aberg,Denise Rodriguez,Florian Krammer,Donna Strauss,Beth H. Shaz,Louella C.F. Rudon,Patricia Galdon,Jeffrey S. Jhang,Suzanne Arinsburg,Ian Baine +17 more
TL;DR: Convalescent plasma for treatment of severe acute respiratory syndrome coronavirus 2 has shown preliminary signs of effectiveness in moderate to severely ill patients in reducing mortality, but the comprehensive incidence and nature of the spectrum of transfusion reactions is unknown.
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma.
Haoli Jin,James C. Reed,Sean T. H. Liu,Hsi en Ho,Joao Pedro Lopes,Nicole B. Ramsey,Omar Waqar,Farah Rahman,Judith A. Aberg,Nicole M. Bouvier,Charlotte Cunningham-Rundles,Hung-Mo Lin,Alexandra Abrams-Downey,Krystal P. Cascetta,Aaron E. Glatt,Sanjana C. Koshy,Erna M. Kojic,Dana Mazo,David C. Perlman,Steven Rudolph,Jason Steinberg,Thomas R. Schneider,Ian Baine,Ania Wajnberg,Jeffrey P. Gumprecht,Denise Rodriguez,Charles Sanky,Amy C. Dupper,Deena R. Altman,Florian Krammer,Damodara Rao Mendu,Adolfo Firpo-Betancourt,Carlos Cordon-Cardo,Jeffrey S. Jhang,Suzanne A. Arinsberg,David Reich +35 more